8-K 1 bd8k503.txt FORM 8-K FOR THE PERIOD ENDED MAY 19, 2003 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 19, 2003 HEMACARE CORPORATION (Exact Name of Registrant as Specified in its Charter) CALIFORNIA (State or other jurisdiction of incorporation) 000-15223 95-3280412 (Commission File No.) (IRS Employer Identification No.) 21101 Oxnard Street Woodland Hills, CA 91367 (Address of principal executive offices and Zip Code) Registrant's telephone number, including area code: (818) 226-1968 2 ITEM 5. OTHER EVENTS AND REGULATION FD DISCLOSURE The text of a press release dated May 19, 2003, issued by HemaCare Corporation ("HemaCare") announcing the appointment of Wm. Andrew Heaton, MD and Terry Van Der Tuuk to its Board of Directors is attached as Exhibit 99.1 hereto and is incorporated by reference herein. ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS (c) Exhibits Exhibit Number Description ------- ----------------------------------------------------- 99.1 Press Release issued by HemaCare, dated May 19, 2003 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: May 19, 2003 HEMACARE CORPORATION /s/ Judi Irving -------------------------- Judi Irving, Chief Executive Officer 2 3 EXHIBIT INDEX Exhibit Number Description ------- ---------------------------------------------------- 99.1 Press Release issued by HemaCare, dated May 19, 2003 3